0001213900-21-026675.txt : 20210517 0001213900-21-026675.hdr.sgml : 20210517 20210517073156 ACCESSION NUMBER: 0001213900-21-026675 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190415 FILED AS OF DATE: 20210517 DATE AS OF CHANGE: 20210517 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Weisblum Eric CENTRAL INDEX KEY: 0001569077 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-54872 FILM NUMBER: 21927562 MAIL ADDRESS: STREET 1: 285 GRAND AVENUE CITY: ENGLEWOOD STATE: NJ ZIP: 07631 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Silo Pharma, Inc. CENTRAL INDEX KEY: 0001514183 STANDARD INDUSTRIAL CLASSIFICATION: APPAREL & OTHER FINISHED PRODS OF FABRICS & SIMILAR MATERIAL [2300] IRS NUMBER: 462137136 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 560 SYLVAN AVE STREET 2: SUITE 3160 CITY: ENGLEWOOD CLIFFS STATE: NJ ZIP: 07632 BUSINESS PHONE: (718) 400-9031 MAIL ADDRESS: STREET 1: 560 SYLVAN AVE STREET 2: SUITE 3160 CITY: ENGLEWOOD CLIFFS STATE: NJ ZIP: 07632 FORMER COMPANY: FORMER CONFORMED NAME: Uppercut Brands, Inc. DATE OF NAME CHANGE: 20190808 FORMER COMPANY: FORMER CONFORMED NAME: Point Capital, Inc. DATE OF NAME CHANGE: 20130130 FORMER COMPANY: FORMER CONFORMED NAME: Gold Swap Inc DATE OF NAME CHANGE: 20110301 4 1 ownership.xml X0306 4 2019-04-15 0 0001514183 Silo Pharma, Inc. SILO 0001569077 Weisblum Eric C/O SILO PHARMA, INC. 560 SYLVAN AVE., SUITE 3160 ENGLEWOOD CLIFFS NJ 07632 1 1 0 0 CEO, CFO and President Common Stock 2019-06-17 4 P 0 57714 0.002 A 57714 D Common Stock 2019-10-15 4 P 0 200 0.38 A 57914 D Common Stock 2019-10-22 4 P 0 200 0.45 A 58114 D Stock Option (right to buy) 0.0001 2019-04-15 4 A 0 100000 0 A 2019-04-15 2024-04-15 Common Stock 100000 100000 D Stock Option (right to buy) 0.0001 2019-04-15 4 A 0 100000 0 A 2019-07-15 2024-07-15 Common Stock 100000 100000 D Stock Option (right to buy) 0.0001 2019-10-15 4 A 0 100000 0 A 2019-10-15 2024-10-15 Common Stock 100000 100000 D The options were granted pursuant to the Employment Agreement by and between the Issuer and the Reporting Person dated April 15, 2019. The options were granted on April 15, 2019 and vested in full on July 15, 2019. /s/ Eric Weisblum 2021-05-17